Semaglutide vs Retatrutide
Current champion vs next-generation challenger. Semaglutide is the FDA-approved GLP-1 agonist, while retatrutide is Eli Lilly's investigational triple agonist (GLP-1/GIP/glucagon) showing even greater weight loss in trials.
Side-by-Side Comparison
| Attribute | Semaglutide | Retatrutide |
|---|---|---|
| Class | GLP-1 Receptor Agonists | GLP-1 Receptor Agonists |
| FDA Legal Status | FDA Approved | In Clinical Trials |
| Evidence Rating | A - Strong Evidence (Multiple RCTs) | B - Moderate Evidence (Some Human Data) |
| Administration | subcutaneous, oral | subcutaneous |
| Half-Life | ~7 days (injectable) | ~6 days |
| Typical Dosage | 0.25mg–2.4mg weekly (injectable); 3mg–14mg daily (oral) | 1mg–12mg weekly (Phase 2 dosing) |
| Primary Uses | Type 2 diabetes, Chronic weight management, Cardiovascular risk reduction | Obesity treatment, Type 2 diabetes, NASH/MAFLD |
Key Differences
- Semaglutide is FDA-approved and available now; retatrutide is still in Phase 3 trials
- Retatrutide activates 3 receptors (GLP-1 + GIP + glucagon) vs semaglutide's 1
- Retatrutide showed 24.2% weight loss at 48 weeks vs semaglutide's 15-17% at 68 weeks
- Retatrutide's glucagon activation may reduce liver fat more effectively
- Semaglutide has years of real-world safety data; retatrutide has limited trial data
When to Consider Semaglutide
- Need treatment now (retatrutide is not yet available)
- Want proven long-term safety data
- Insurance coverage available
- Prefer oral option (Rybelsus)
When to Consider Retatrutide
- Once approved — for maximum weight loss potential
- Liver fat reduction is a goal (NASH/MAFLD)
- Didn't achieve adequate results with GLP-1 alone
- Willing to participate in clinical trials
Can They Be Stacked?
Not recommended - Semaglutide and Retatrutide should generally not be combined.
Frequently Asked Questions
What is the difference between Semaglutide and Retatrutide?
Current champion vs next-generation challenger. Semaglutide is the FDA-approved GLP-1 agonist, while retatrutide is Eli Lilly's investigational triple agonist (GLP-1/GIP/glucagon) showing even greater weight loss in trials.
Can Semaglutide and Retatrutide be used together?
Semaglutide and Retatrutide are generally not recommended to be used together.
Which is better, Semaglutide or Retatrutide?
The choice depends on your specific needs. Consider Semaglutide if you need treatment now (retatrutide is not yet available). Consider Retatrutide if you once approved — for maximum weight loss potential. Consult a healthcare provider for personalized advice.